Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (93 ops.)
Latest filing published 31 Jul 2026 for Kiniksa Pharmaceuticals International, plc.
Filing timeline
BuySaleG. Bradley Cole
Insider track record
Disclosed buys
0
Disclosed sells
93
Signal history
G. Bradley Cole: trading record in brief
G. Bradley Cole was CFO of Genomic Health Inc (150 filings, 86 sales) then moved to Exact Sciences Corp, as General Manager, Diagnostics (6 filings, 3 sales), and sits as a Director at Castle Biosciences Inc (8) and Kiniksa Pharmaceuticals International, plc (6). The record's 92 sales total EUR 24.5 million, a median of EUR 129,811, and no purchase appears. The three largest are EUR 3,840,336 on August 12, 2019 at Genomic Health, EUR 2,534,041 on February 19, 2020 and EUR 2,032,633 on November 21, 2019 at Exact Sciences.
Of 170 filings published from January 14, 2016 to July 31, 2026, there are also 64 option exercises, 8 grants and 6 lines of another kind. The peak is 56 filings in 2019, ahead of 44 in 2018, then 4 in 2020 and 1 to 2 a year from 2022 to 2025. Seven filings fall in the last twelve months, 3 of them sales. Publication comes a median of 2 days after the trade.
At Genomic Health Inc, Steven Shak is within 30 days of 74 of Cole's market trades, James J. Vaughn and Kimberly J. Popovits of 72, Baker Bros. Advisors LP of 37 and Frederic Pla of 33, always in the same direction.
Companies and markets linked to G. Bradley Cole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations170 total
4,500 shares0Class A Ordinary ShareSEC:0001337798-26-000004:1
3,673 shares@ US$81.430.0001% mcap50.0% of flowClass A Ordinary ShareSEC:0001337798-26-000004:0
2,799 sharesClass A Ordinary ShareSEC:0001337798-26-000002:0
13,667 sharesCommon StockSEC:0001447362-26-000011:0
4,748 shares@ US$28.4459.5% of flowCommon StockSEC:0001447362-26-000008:1
2,655 shares@ US$28.5133.4% of flowCommon StockSEC:0001447362-26-000008:2
4,748 shares@ US$3.38100.0% of flowCommon StockSEC:0001447362-26-000008:0
3,173 sharesClass A Ordinary ShareSEC:0001415889-25-015805:0
8,673 sharesCommon StockSEC:0001447362-25-000087:0
4,373 sharesClass A Common ShareSEC:0001415889-24-016009:0
8,636 sharesCommon StockSEC:0001447362-24-000094:0
5,000 sharesClass A Common ShareSEC:0001415889-23-010560:0
3,825 sharesCommon StockSEC:0001447362-23-000105:0
830 shares0Common StockSEC:0001447362-22-000117:0
3,934 shares@ US$35.282.2% of flowCommon StockSEC:0001209191-20-011595:0
13,422 shares@ US$35.917.5% of flowCommon StockSEC:0001209191-20-011595:1
27,356 shares@ US$100.0042.6% of flowCommon StockSEC:0001209191-20-011595:2
10,000 shares@ US$90.3013.6% of flowCommon StockSEC:0001209191-20-004038:0
12,334 shares0Common StockSEC:0001209191-19-061534:0
28,016 shares@ US$80.3834.2% of flowCommon StockSEC:0001209191-19-057962:0
27,385 shares0Common StockSEC:0001209191-19-056631:0
11,794 shares0Common StockSEC:0001209191-19-056631:1
22,560 shares@ US$30.842.9% of flowCommon StockSEC:0001209191-19-052834:0
22,560 shares@ US$69.016.6% of flowCommon StockSEC:0001209191-19-052834:1
25,000 shares@ US$28.052.9% of flowCommon StockSEC:0001209191-19-049152:0
25 of 170 declarations
